Chemo- and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary

Clinical Practice ◽

Targeted Therapy ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Faculty Opinions recommendation of Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718375446.793525557 ◽

2016 ◽

Author(s):

Daniel Vorobiof

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

American Society ◽

Positive Breast Cancer

Faculty Opinions recommendation of Human epidermal growth factor receptor 2 testing in breast cancer: american society of clinical oncology/college of american pathologists clinical practice guideline focused update.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733321759.793562854 ◽

2019 ◽

Author(s):

Sherene Loi

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Practice Guideline ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline

Breast Diseases A Year Book Quarterly ◽

10.1016/j.breastdis.2015.07.019 ◽

2015 ◽

Vol 26 (3) ◽

pp. 223-225

Author(s):

M.A. Edson ◽

J. Li

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Disease Management ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

American Society ◽

Positive Breast Cancer

Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Clinical Practice Guideline Update Summary

Journal of Oncology Practice ◽

10.1200/jop.18.00290 ◽

2018 ◽

Vol 14 (8) ◽

pp. 501-504 ◽

Cited By ~ 10

Author(s):

Sharon H. Giordano ◽

Sarah Temin ◽

Nancy E. Davidson

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Practice Guideline ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Positive Breast Cancer

American Society of Clinical Oncology/College of American Pathologists Human Epidermal Growth Factor Receptor 2 Testing Clinical Practice Guideline Upcoming Modifications: Proof That Clinical Practice Guidelines Are Living Documents

Archives of Pathology & Laboratory Medicine ◽

10.5858/arpa.2015-0074-ed ◽

2015 ◽

Vol 139 (8) ◽

pp. 970-971 ◽

Cited By ~ 14

Author(s):

M. Elizabeth H. Hammond ◽

David G. Hicks

Keyword(s):

Clinical Practice ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Practice Guidelines ◽

Practice Guideline ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Responses: Re: Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Xenografts With Multiagent Human Epidermal Growth Factor Receptor-Targeted Therapy

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/djm178 ◽

2007 ◽

Vol 99 (21) ◽

pp. 1645-1646

Author(s):

T. J. Powles ◽

S. Ashley ◽

I. E. Smith ◽

M. Dowsett

Keyword(s):

Breast Cancer ◽

Targeted Therapy ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Epidermal Growth ◽

Breast Cancer Xenografts

Abstract P3-06-10: All-cause resource use among elderly breast cancer patients by receipt of human epidermal growth factor receptor 2-targeted therapy: An analysis of US national data 2006-2009

10.1158/0008-5472.sabcs13-p3-06-10 ◽

2013 ◽

Author(s):

Y Hao ◽

K Lang ◽

H Huang ◽

V Federico ◽

J Menzin

Keyword(s):

Breast Cancer ◽

Targeted Therapy ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Resource Use ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

National Data ◽

Epidermal Growth

National Guidelines and Level of Evidence: Comments on Some of the New Recommendations in the American Society of Clinical Oncology and the College of American Pathologists Human Epidermal Growth Factor Receptor 2 Guidelines for Breast Cancer

Journal of Clinical Oncology ◽

10.1200/jco.2014.59.7211 ◽

2015 ◽

Vol 33 (11) ◽

pp. 1301-1302 ◽

Cited By ~ 24

Author(s):

Emad A. Rakha ◽

Marian Pigera ◽

Abeer Shaaban ◽

Sandra J. Shin ◽

Timothy D'Alfonso ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Oncology ◽

Growth Factor Receptor ◽

National Guidelines ◽

Level Of Evidence ◽

Epidermal Growth ◽

Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Xenografts With Multiagent HER-Targeted Therapy

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/djk151 ◽

2007 ◽

Vol 99 (9) ◽

pp. 694-705 ◽

Cited By ~ 135

Author(s):

G. Arpino ◽

C. Gutierrez ◽

H. Weiss ◽

M. Rimawi ◽

S. Massarweh ◽

...

Keyword(s):

Breast Cancer ◽

Targeted Therapy ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Epidermal Growth ◽

Breast Cancer Xenografts

Responses: Re: Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Xenografts With Multiagent Human Epidermal Growth Factor Receptor-Targeted Therapy

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/djm177 ◽

2007 ◽

Vol 99 (21) ◽

pp. 1644-1645

Author(s):

U. Veronesi ◽

B. Bonanni ◽

A. Decensi

Keyword(s):

Breast Cancer ◽

Targeted Therapy ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Epidermal Growth ◽

Breast Cancer Xenografts